Molbio Diagnostics is a SME IPO on NSE, currently open. The price band is ₹807 per share. The current grey market premium (GMP) is +₹127 (15.74% over the upper band) — an unofficial, unregulated figure, not a forecast.
Grey market premium
Bidding
live…
Closes
Open
No live subscription data yet.
Calculator unavailable — price band or lot size not published yet.
Aggregated and reconciled from multiple public sources · updated 50s ago.
Grey Market Premium (GMP) is an unofficial, unregulated and speculative number reported by third-party websites. It is not an official price, not a guarantee of listing performance, and not investment advice. Platform is an information aggregator — not a SEBI-registered investment adviser or research analyst, and it gives no buy/sell/apply recommendations. Subscription and date figures can lag the exchanges. Always confirm with NSE, BSE and the offer document before making any decision.
Registrars protect these pages with a CAPTCHA on their side — you complete that one step and enter your PAN there. This site never sees or handles your PAN. Bigshare's status site is often busy on allotment day; retry after a few minutes.
Headlines via Google News — third-party reports, not verified or endorsed by Platform.